A Pilot Study to Determine Fructose Uptake by Primary Human Colorectal Tumors
NCT05136092 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2024-11-06
Summary
This proposed study is designed to investigate the specific uptake of fructose by human colorectal tumors. In this study, subjects with colorectal cancer undergoing surgery will receive an oral sugar solution containing fructose or xylose prior to surgery. The tumor will then be resected, and a portion of the tissue will be used to measure the abundance of fructose and xylose. The study hypothesis is that the tumors will take up fructose sugar but not xylose sugar. A comparison of the sugar uptake between the tumor and normal tissues from the adjacent intestinal epithelium and smooth muscle and the liver will be conducted. This proposal will confirm that human colorectal cancer tumors can directly absorb dietary sugars, which has never been demonstrated.
Conditions
- Colorectal Tumors
Interventions
- DIETARY_SUPPLEMENT
-
Cohort 1: HFCS (fructose) fed
Two to three hours before surgery. Subjects will prepare the sugar solutions (Fructose-containing solution: 250 mL of water containing 41.25 g of D-Fructose and 33.75 g of D-Glucose) by adding 250 ml water to the sugar powder provided by the study team and drink it between two and three hours before surgery. Samples collected before surgery: * Blood sample of 5 ml * Urine Samples 5 ml Day of Surgery The anesthesia and surgical procedure will undergo as per regular care. Samples collection at the time the surgical specimen is removed * Blood sample of 5 ml blood will be obtained from the IV line * Tissue samples * 2 Tumor tissue samples 5mmx5mmx5mm, * 2 Intestinal /colon tissue samples 5mmx5mmx5mm * 2 tissue samples from mesentery tissue 5mmx5mmx5mm * Optional Liver Biopsy - a 3-5 mm liver tissue will be obtained for research. * Urine Samples 5 ml
- DIETARY_SUPPLEMENT
-
Cohort 2: D-Xylose (xylose-fed)
Two to three hours before surgery. Subjects will prepare the sugar solutions (Xylose-containing solution: 250 mL of water containing 41.25 g of D-Xylose and 33.75g of D-Glucose) by adding 250 ml water to the sugar powder provided by the study team and drink it between two and three hours before surgery. Samples collected before surgery: * Blood sample of 5 ml * Urine Samples 5 ml Day of Surgery The anesthesia and surgical procedure will undergo as per regular care. Samples collection at the time the surgical specimen is removed * Blood sample of 5 ml blood will be obtained from the IV line * Tissue samples * 2 Tumor tissue samples 5mmx5mmx5mm, * 2 Intestinal /colon tissue samples 5mmx5mmx5mm * 2 tissue samples from mesentery tissue 5mmx5mmx5mm * Optional Liver Biopsy - a 3-5 mm liver tissue will be obtained for research. * Urine Samples 5 ml
Sponsors & Collaborators
-
Weill Medical College of Cornell University
lead OTHER
Principal Investigators
-
Mehraneh D Jafari, MD · Weill Medical College of Cornell University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-02-16
- Primary Completion
- 2024-08-27
- Completion
- 2024-09-27
Countries
- United States
Study Locations
More Related Trials
-
Presence of Circulating Tumor DNA in Colorectal Cancer
NCT01198743 ·Status: COMPLETED
-
Attitudes Towards Prophylactic Colectomy in Hereditary Non-polyposis Colorectal Cancer (HNPCC) Patients
NCT00582452 ·Status: COMPLETED
-
Prebiotics in Rectal Cancer
NCT05516641 ·Status: UNKNOWN ·Phase: NA
-
Prognosis Predicting of CRC Patients Based on Morphology and Molecular Biomaker of CTC
NCT04912882 ·Status: NOT_YET_RECRUITING
-
Implementing a Multilevel Intervention to Accelerate Colorectal Cancer Screening and Follow-up
NCT04514341 ·Status: COMPLETED
-
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
NCT00899626 ·Status: RECRUITING
-
Diet and Physical Activity Intervention in CRC Survivors
NCT01708824 ·Status: UNKNOWN ·Phase: PHASE2
-
Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon Cancer
NCT00550628 ·Status: COMPLETED
-
A Pilot Study to Explore the Role of Gut Flora in Colorectal Cancer
NCT04148378 ·Status: WITHDRAWN
-
High-Dose Folic Acid in Preventing Colorectal Cancer in Patients Who Have Had Polyps Surgically Removed
NCT00002650 ·Status: COMPLETED ·Phase: PHASE2
-
Microbiome in Colorectal Cancer Onset and Progression
NCT05368688 ·Status: TERMINATED
-
Understanding Sugar-Sweetened Beverages (SSB) and Colorectal Cancer (CRC)
NCT06669923 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Follow-up After Surgery for Colorectal Cancer
NCT05656326 ·Status: ACTIVE_NOT_RECRUITING
-
Multilevel Intervention Based on Colorectal Cancer (CRC) and Cervical Cancer Self-screening in Rural, Segregated Areas
NCT04471194 ·Status: COMPLETED ·Phase: NA
-
Investigating the Use of Fluorescent Lectins to Identify Dysplasia and Cancer During Endoscopy and Surgery
NCT03070613 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Colorectal Cancer Detection by Means of Optical Fluoroscopy
NCT01286064 ·Status: UNKNOWN ·Phase: NA
-
Gut Microbiome in Colorectal Cancer
NCT04054908 ·Status: COMPLETED
-
Study of Biomarkers in Blood & Tissue Samples From Patients With Colorectal Cancer or Polyps & Patients Without Polyps
NCT00898378 ·Status: COMPLETED
-
Testing for Safety and Colorectal Cancer Preventive Effects of ONC201
NCT05630794 ·Status: RECRUITING ·Phase: PHASE1
-
Evaluation of a Model for the Early Diagnosis of Colorectal Cancer by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA to the Community Colorectal Cancer Screening Program
NCT05638243 ·Status: UNKNOWN
-
Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy
NCT06034197 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Do Patients With Colorectal Cancer Understand That Their Family is at Risk?
NCT00145860 ·Status: TERMINATED
-
Tumor Deposits in Cancer Colon
NCT04773626 ·Status: UNKNOWN
-
Oral Green Tea Extract and Milk Thistle Extract to Colorectal Cancer Patients Undergoing Resection
NCT01239095 ·Status: TERMINATED ·Phase: PHASE1
-
Colorectal Cancers :A Retrospective Study
NCT07024225 ·Status: RECRUITING